Breaking: Surge in China's Benign Prostatic Hyperplasia Treatment Market Size Predicted
In a significant shift for healthcare in China, the benign prostatic hyperplasia treatment market is projected to achieve a remarkable valuation of approximately 1,346.34 million USD by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 5.5%, indicating robust expansion fueled by an increasing prevalence of the condition among the aging population. The demand for...
0 Commenti 0 condivisioni 382 Views 0 Anteprima
social art-inpa https://social.art-inpa.com